Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability.
Cell Rep
; 42(12): 113503, 2023 12 26.
Article
in En
| MEDLINE
| ID: mdl-38019654
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunoconjugates
/
Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Cell Rep
Year:
2023
Type:
Article
Affiliation country:
United States